Skip to main content
logo
argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
775.03
-8.71 (-1.11%)
At close: Apr 28, 2026, 4:00 PM EDT
771.50
-3.53 (-0.46%)
After-hours: Apr 28, 2026, 5:20 PM EDT

argenx SE Revenue

In the year 2025, argenx SE had annual revenue of $4.25B with 88.63% growth. argenx SE had revenue of $1.32B in the quarter ending December 31, 2025, with 73.69% growth.

Revenue (ttm)
$4.25B
Revenue Growth
+88.63%
P/S Ratio
11.44
Revenue / Employee
$2,274,004
Employees
1,863
Market Cap
48.47B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.25B2.00B88.63%
Dec 31, 20242.25B983.45M77.52%
Dec 31, 20231.27B823.32M184.91%
Dec 31, 2022445.27M-94.15M-17.45%
Dec 31, 2021539.42M474.51M731.01%
Dec 31, 202064.91M49.35M317.09%
Dec 31, 201915.56M6.66M74.77%
Dec 31, 20188.90M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Regeneron Pharmaceuticals14.34B
Vertex Pharmaceuticals12.00B
Incyte5.36B
BeOne Medicines AG5.34B
Alnylam Pharmaceuticals3.71B
BioNTech SE3.37B
Royalty Pharma2.38B
Moderna1.94B
Revenue Rankings

ARGX News

More News